Navigation Links
Exhaustive Study to Expand the Efficacy of Drug L-dopa for Parkinson's

Parkinson's sufferers are usually treated with the drug called levodopa or L-dopa that helps in reviving cellular communication//. After prolonged use of the drug, many patients may experience motor complications and a reduced response to the drug.

Parkinson's disease is a slow process of destruction of brain cells which produce dopamine. As dopamine levels fall, the symptoms of Parkinson’s shows up as tremors in the arms, legs and face. The patients visibly portray slow movement, lack of proper balance and coordination.

A new clinical trial is underway to evaluate the effectiveness of a novel drug to treat Parkinson’s, which could extend the benefits of he existing drug, L-dopa. The study will also investigate the potential of the drug, E2007, and its contribution in extending the effectiveness of L-dopa.

The prevailing treatment for Parkinson's disease aims to revive cellular communication by simply restoring the lost dopamine with L-dopa. Though this therapy is effective for sometime, yet it is unable to halt the gradual decline so evident in long time Parkinson’s sufferers.

"The hope is that by altering dopamine transmission through the modulating the activity of AMPA receptors, there will be measurable effects on the dopamine system," said Dr. Liang.

The study has been tailored to suit patients suffering advanced Parkinson's and have been undergoing L-dopa treatment for a considerable period of time. The study will involve nearly 700 patients from more than 100 centers across the U.S., Canada, Australia, New Zealand and South America.

Dr. Kremens said, "It's an interesting approach and an exciting trial because it is exploring a drug in a new therapeutic category. L-dopa is still the gold standard and we haven't come up with a better dopamine as yet."

Page: 1

Related medicine news :

1. Dolly Paves the Way for Exhaustive Stem Cell Research
2. Cancer Drug Helps An Anti-Cancer Virus To Act More Exhaustively
3. Tomato Sauce reduces Cancer Risk- Study
4. Study on obesity and heart failure
5. National Lung Study in the process
6. Study casts doubt on keyboard ills
7. Study reveals how stress can make you sick
8. Study reveals how stress can make you sick
9. Study supports vegetable diet
10. Study to look at early surgery to treat epilepsy
11. Its Never Too Late to Stop Smoking,Study Finds
Post Your Comments:

(Date:11/30/2015)... ... November 30, 2015 , ... The ... prostate cancer education and prevention—is joining forces with the award-winning creator and writer ... elegance on December 7, 2015 at the Union League of Philadelphia. , ...
(Date:11/30/2015)... ... November 30, 2015 , ... The American Society for Clinical Pathology (ASCP) ... AIDS Day 2015. On Nov. 30, ASCP shared its “Give a minute. Get tested. ... Day and the importance of getting tested for HIV. , ASCP has asked members ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... as their exclusive channel partner for the Nutraceutical Specialties products into oral solid ... US, effective immediately. , “We are pleased to announce our expanded distribution ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... Michael Hansen, Ph.D., a senior scientist at Consumer Reports as supporting a “A ... a child’s exposure limits. , The original Nov 2015 CR story titled, “Does ...
(Date:11/30/2015)... Calif. (PRWEB) , ... November 30, 2015 , ... ... and Analytics for the last 15 years, announced today that Michigan-based Family Health ... provider of care for over 45 years, FHC was awarded the largest Affordable ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... , November 30, 2015 ... directed at up to 10 G protein-coupled receptor (GPCR) ... ) to research and develop potential new medicines directed ... across multiple therapeutic areas. --> Heptares Therapeutics ... company and wholly-owned subsidiary of Sosei Group Corporation ("Sosei"; ...
(Date:11/30/2015)... , November 30, 2015 Elbit ... the "Company") announced today that it was informed by InSightec ... Drug Safety (MFDS) has approved its Exablate Neuro system ... --> --> Insightec,s Exablate Neuro ... alternative that combines two technologies: Focused Ultrasound, which is ...
(Date:11/29/2015)... 29, 2015   Royal Philips  (NYSE: PHG, AEX: ... at the 2015 Radiological Society of North America Annual ... Place in Chicago . Visitors to ... company,s broad portfolio of integrated Diagnostic Imaging, Clinical Informatics, ... clinical performance, improve workflow and create a superior patient ...
Breaking Medicine Technology: